Delivery Order SPE2DB24D9314-SPE2DB25FKRLK

Award Date 5/13/25
Potential Completion Date 5/14/25
Potential Value $19K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $37,053.68 firm fixed-price delivery order contract is for the supply of TRIKAFTA 100-50-75 MG/150 MG medication to support the recurring medical needs of military health facilities worldwide. DMS Pharmaceutical Group holds a significant $499,999,999 single-award indefinite delivery contract...
This federal contract award, valued at $19,316.57, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of TRIKAFTA 100-50-75 MG/75MG PKT 14S, a pharmaceutical product, with a period of performance through April 16, 2025. DMS Pharmaceutical Group Inc. holds a significant Indefinite Delivery Contract (IDC) with the DLA, valued at $499,999,999 and valid through November...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $18,526.83 firm fixed-price delivery order is for TRIKAFTA 80-40-60MG/59.5MG PKT 14S, a specialized pharmaceutical product. DMS Pharmaceutical Group holds a $499,999,999 single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the DLA to issue delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $37,053.68 firm fixed-price delivery order is part of DMS Pharmaceutical Group's larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the DLA to issue orders for a comprehensive range of pharmaceutical items to support the recurring medical...
This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, worth up to $74,107.32, is for the delivery of TRIKAFTA 100-50-75 MG/75MG PKT 14S, a pharmaceutical product, with a completion date of May 8, 2024. This is a firm fixed-price delivery order contract, and there is no set-aside designation. DMS Pharmaceutical Group holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $68,514.54 firm fixed-price delivery order is for the supply of the drug TRIKAFTA 100-50-75 MG/150 MG, with a performance period through August 2, 2024. DMS Pharmaceutical Group holds a larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the...
The U.S. Defense Logistics Agency (DLA) awarded a $18,526.83 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the pharmaceutical product TRIKAFTA 80-40-60MG/59.5MG PKT 14S, with a period of performance through July 2, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $499,999,999 that DMS Pharmaceutical Group holds with DLA to provide a...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $37,053.68 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The award is under the SPE2DB program, a multi-year indefinite delivery vehicle DMS Pharmaceutical Group holds with DLA valued at up to $4,999,999 for a broad range of pharmaceutical products. This order is for TRIKAFTA, a prescription medication, with an ultimate completion date of April 3,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $74,107.36 firm fixed-price delivery order is for the supply of TRIKAFTA 50-25-37.5 MG/75 MG pharmaceutical product. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which enables the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $55,580.49, is a firm fixed-price delivery order for the pharmaceutical product Trikafta (80-40-60mg/59.5mg, 14-count packets). DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency...
  • SPE2DB24D9314
    Indefinite Delivery Contract
  • SPE2DB24D9314-SPE2DB25FKRLK
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $19,316.57 firm-fixed-price delivery order is for the supply of TRIKAFTA 100-50-75 MG/75MG PKT 14S, a pharmaceutical product. The contract has an ultimate completion date of May 14, 2025.

DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue delivery orders for a comprehensive range of pharmaceutical items supporting the medical supply needs of military health facilities worldwide. This positioning establishes DMS Pharmaceutical Group as a critical supplier in the federal pharmaceutical supply chain, providing direct distribution of prescription drugs and pharmacy services to Department of Defense healthcare sites.

Generated 8/12/25, 11:44 AM